MedCity News

JUNE 1, 2023

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. As of October 2020, most health plans are required to disclose costs in a machine-readable format that also includes descriptions of typically cryptic billing codes in plain-language descriptions.

Patients 312

Patients Healthcare Healthcare Electronics 312

Pharma Marketing Network

NOVEMBER 11, 2020

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact . Rea ching HCP’s When Your Sales Force Can’t.

Marketing 52

Marketing Pharma Competition Doctors 52

World of DTC Marketing

MAY 26, 2021

In 2020 alone, AbbVie collected $16 billion in U.S. billion in 2020. billion in 2020. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars. Here is the executive summary from the report. net revenue for Humira. AbbVie’s yearly U.S. AbbVie’s U.S.

Competition 180

Competition Marketing Government Patients 180

World of DTC Marketing

JUNE 13, 2022

Health insurance is costly for both employees and employers: The average employer cost, including premiums, rose this year to an estimated $13,360 per employee, up from $12,501 in 2020. Employee contributions for premiums increased slightly to $3,331 in 2021, up from $3,269 in 2020.

Insurance 201

Insurance Healthcare Healthcare Consulting 201

Infuse Medical

MAY 4, 2021

Let’s face it: 2020 changed things for a lot of business. For many companies, 2020 not only forced them to reimagine their sales experience, but it also showed sales managers the weaknesses in their overall sales process. Study Your Competition That is Crushing It. The reality is that 2020 shook up a lot of things.

Sales Strategy 130

Sales Strategy Sales Medical Sales process 130

World of DTC Marketing

JULY 27, 2022

Those health insurers, in turn, use the discounts to offer more competitive premiums in a bid to attract enrollees. In 2020, the value of these coupons totaled $14 billion. PBMs skim off a substantial share of the negotiated savings for themselves and pass the rest to insurers.

Insurance 226

Insurance Prescription Medicine Medical 226

Healthcare Success

DECEMBER 2, 2024

7 Ways Your Value Proposition Helps Grow Your Healthcare Business Marked by disruptors and innovations like telehealth, advancing technologies, and evolving consumer expectations, the healthcare industry has become more competitive than ever. A good brand reputation can help elevate your brand in a competitive environment.

Patients 59

Patients Marketing Healthcare Healthcare 59

Sales Talent

JULY 16, 2020

unemployed persons in the US in May 2020, which is up from 5.8M in February 2020. This flood of competition means that employers have choices, and job seekers need to sharpen their interviewing skills. Adding to this is the recent dramatic increase in the unemployment rate due to the pandemic. All the best, Chris.

B2B Sales 162

B2B Sales Sales Prospecting Management 162

pharmaphorum

JULY 22, 2022

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. ” The post Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe appeared first on.

Competition 111

Competition Pharma Marketing Patients 111

World of DTC Marketing

OCTOBER 5, 2021

For 17 of the 20 top-selling drugs worldwide in 2020, pharmaceutical corporations made more money from U.S. Its immense power relative to most of the other stakeholders in the $3.5 trillion health care sector stems from many factors, but it begins from what it does. According to Public Citizen : U.S. In other words, the U.S.

Pharma 241

Pharma Insurance Sales Government 241

Sales Talent

JANUARY 20, 2022

However, before you jump directly to our sales hiring predictions for 2022, take the time to read the entire article to learn how the intense competition for talent is impacting sales professionals’ salaries and employers’ strategies for winning the talent war. By the end of December 2020, the unemployment rate had dropped to 6.7%

Sales 130

Sales B2B Sales Competition Insurance 130

Integrity Solutions

AUGUST 28, 2019

How comfortable are you taking your current salespeople—with the level of performance and skills they have right now—into an increasingly competitive marketplace? I probably can’t win in such a competitive market. The business environment isn’t getting any easier to navigate. I’m afraid I can’t make that quota. (a

Training 45

Training Sales Sales Management Management 45

Pharmaceutical Technology

MARCH 8, 2023

These two insulin therapies have been off patent for about a decade but have a list price of about $500 for a pack of five injection pens and currently have limited competition from biosimilars. At $92 for a five-pack of injections, Rezvoglar is a 78% discount on the price of Lantus.

Competition 106

Competition Insurance Leads Marketing 106

Clarivate

DECEMBER 19, 2022

Either way, competition over employed providers among Medicare Advantage plans has only begun to heat up and UnitedHealth remains the plan to beat. Medicare provider competition appeared first on Clarivate. To learn more about how Clarivate helps life science companies navigate the fast-changing U.S.

Competition 52

Competition Retail Insurance Marketing 52

Medical Device Success

OCTOBER 18, 2020

Reading time: 2 – 3 minutes In January 2018 when Dominik Beck took the helm of Rudolf Riester, GmbH, he began executing a plan to put Riester in a more competitive position against its larger rivals. Then in early 2020 Covid spread across the world. Then in early 2020 Covid spread across the world.

Leads 100

Leads Doctors Medical Competition 100

Pharmaceutical Technology

SEPTEMBER 15, 2022

The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%

Sales 109

Sales Competition Pharmaceutical Pharmaceutical research 109

Evolve Your Success

SEPTEMBER 11, 2024

With her unique expertise in both marketing and enterprise software, Anne sheds light on the groundbreaking changes brought about by the 2020 law that mandates insurance companies to disclose negotiated rates. Anne Saulnier, the trailblazing CEO of Hex IQ, joins us to reveal how reimbursement data is revolutionizing healthcare sales.

Sales 130

Sales Medical sales reps Medical sales Healthcare 130

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 98

Government Recruitment Medicine Patients 98

Copyright Clearance Center

MAY 16, 2023

Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries. Tom Ogier, CCC’s Director of Client Engagement and Solutions, was named a silver winner for Customer Service Executive of the Year in the 2020 Best in Biz Awards.

Competition 98

Competition Sales 98

Clarivate

JANUARY 28, 2024

Competition for funding is tough and researchers need help to make their grant applications stand out. While some funding programs have seen spending increase year over year, the competition remains tough: researchers often face just a 10 – 20% chance of winning a grant award. in 2022 was 20.7%.

Competition 111

Competition Government 111

European Pharmaceutical Review

JANUARY 2, 2024

Pharma pushes for UK medicine scheme revision Drug pricing was considered as the most negative emerging regulatory and macroeconomic trend, impeding growth for the industry, based on GlobalData’s 2019, 2020, 2021, and 2022 industry outlooks.

Pharma 102

Pharma Medicine Marketing Government 102

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 98

Medicine Healthcare Healthcare Manufacturing 98

European Pharmaceutical Review

NOVEMBER 3, 2022

Competitiveness. It found in 2020, at the height of the pandemic, confidence dipped significantly, however scores have risen globally in the past two years. The US was found to be the leading country within the industry and has one of the highest growth scores in the survey’s history. Finished Dosage. Knowledge of professionals.

Pharma 103

Pharma Manufacturing Competition Pharmaceutical products 103

Clarify Health

MARCH 2, 2021

The hospital strategy team anticipates and plans for changing market dynamics, competitive pressures, consumer behaviors, technological advances, evolving regulations, and macro and micro factors that impact health. For many hospitals in 2020, strategy had to take a backseat. Instead of opening new facilities [.].

Competition 52

Competition Marketing 52

Clarity Engagement Solutions

FEBRUARY 12, 2021

In 2020 most pharmaceutical companies continued their strategic planning as if by 2021 everything would be back to normal. We know of several companies that are doing great, DESPITE what 2020 threw at them. Leaving the competition in their wake. Oh no, 2021 has started and our plan is already outdated! Sounds familiar?

Healthcare 91

Healthcare Healthcare Management Competition 91

European Pharmaceutical Review

APRIL 28, 2023

Yet the EFPIA President cautioned that while the revised legislation was meant to “improve Europe’s competitiveness, the ‘net’ impact of policies set out across these proposals, in their current form, puts European competitiveness at risk.”

Pharmaceutical 98

Pharmaceutical Pharma Medicine Competition 98

Clarivate

NOVEMBER 16, 2021

These highly cited papers rank in the top 1% by citations for field and year from 2010 – 2020. We’re pleased to showcase some institutions that excel in a competitive global environment, supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research.

Government 136

Government Competition Recruitment Leads 136

pharmaphorum

JANUARY 24, 2023

Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

Clarity Engagement Solutions

FEBRUARY 12, 2021

In 2020 most pharmaceutical companies had to shift strategies to reach their customers via multi-channel, digital platforms, with hope that by 2021, everything would be back to normal. Clarity helped them with the “how” to truly engage with healthcare stakeholders and they left the competition in their wake.

Healthcare 91

Healthcare Healthcare Competition Management 91

Integrity Solutions

AUGUST 19, 2019

In a complex, highly competitive marketplace, bank leaders and managers who make it a priority to create a culture that is built around understanding what the customer needs and values—and the mindset necessary to deliver on it—will have the advantage. Part 1 in a new blog series. By Donna Horrigan. Shifting Culture to Drive Growth.

Competition 115

Competition Retail Management Marketing 115

European Pharmaceutical Review

JUNE 24, 2022

These events led to the publication of the EU Pharmaceuticals Strategy in 2020, 1 which, in addition to a range of other activities, aims to ensure the regulatory system for human medicines is future?proof He focuses his practice on EU regulatory affairs, litigation and competition law issues affecting the life sciences sector in Europe.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

Integrity Solutions

MAY 26, 2022

employees said their workplaces had a strong ethical culture in 2020, compared with 1 in 10 who felt that way in 2000. employees experienced 2x more pressure in 2020. Of course, 2020 was a significant and uniquely challenging year for many reasons. According to the 2021 Global Business Ethics Survey® , around 1 in 5 U.S.

Ethics 130

Ethics Sales Training Specialization 130

European Pharmaceutical Review

AUGUST 22, 2022

The report found that while outsourcing was growing, with outsourced activities cited in 26 areas – up from 18 in 2020 – the majority continue to be specialised, repetitive, non-core or less technical activities such as fill/finish, analytical and sterility testing, and routine testing. percent), toxicity testing (79.4

Biopharma 98

Biopharma Manufacturing Marketing Competition 98

PM360

AUGUST 9, 2022

Most recently, he took over the then-called Impel NeuroPharma in May 2020—at the height of the pandemic—and since then has led the company through its first product approval, undergone an initial public offering (IPO), rebranded to Impel Pharmaceuticals, and attracted big interest from Big Pharma in its novel drug delivery technology.

Pharmaceutical 72

Pharmaceutical Physicians Pharma Competition 72

Clarivate

JULY 3, 2024

However, to realize the promise of these and other innovations, MedTech companies must navigate a fast-changing clinical, competitive and regulatory environment that presents a complex web of challenges. Read the full MedTech Trends to Watch 2024 report here.

Competition 52

Competition Medical Marketing Government 52

Pharma Leaders

JUNE 26, 2023

At issue is whether Forest Laboratories, which AbbVie acquired in 2020 as part of its acquisition of Allergan, conspired with six generics makers to delay competition for Bystolic by granting reverse payments in exchange for the generics companies dropping their Bystolic patent challenges for eight years.

Competition 52

Competition Pharmaceutical Healthcare Healthcare 52

European Pharmaceutical Review

FEBRUARY 2, 2023

Between 2000 and 2020, Asian companies outperformed European companies for new approvals of CEPs, increasing their number CEPs from 183 to 2,369. In the meantime the global competition to secure the production and supply of essential medicines is intensifying, and Europe needs to step up and face the challenge if it wants to stay in the race.

Medicine 111

Medicine Manufacturing Pharmaceutical Specialization 111